The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ENGOT-en9/LEAP-001: A phase III study of first-line pembrolizumab plus lenvatinib versus chemotherapy in advanced or recurrent endometrial cancer.
 
Christian Marth
No Relationships to Disclose
 
Christof Vulsteke
Consulting or Advisory Role - Astellas Pharma; Roche
Research Funding - Ipsen; Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Maria Jesus Rubio Pérez
No Relationships to Disclose
 
Vicky Makker
Honoraria - Eisai; Merck; Merck
Consulting or Advisory Role - ArQule; Eisai; Karyopharm Therapeutics; Merck; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Eisai; Lilly; Merck; Takeda
Travel, Accommodations, Expenses - Eisai; Karyopharm Therapeutics; Merck
Other Relationship - IBM
 
Elena Ioana Braicu
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; MSD; Roche; Tesaro
Consulting or Advisory Role - Abbvie; AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline; ImmunoGen; MSD; Roche; Takeda; Tesaro
Research Funding - Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; MSD; Roche
 
Iain A. McNeish
Honoraria - Tesaro
Consulting or Advisory Role - AstraZeneca; Carrick Therapeutics; Clovis Oncology; Takeda; Tesaro
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Radoslaw Madry
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline
Speakers' Bureau - AstraZeneca; GlaxoSmithKline; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche
 
Ali Ayhan
No Relationships to Disclose
 
Kosei Hasegawa
Honoraria - AstraZeneca; Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; MSD K.K
Consulting or Advisory Role - Kaken Pharmaceutical; MSD K.K
Research Funding - Daiichi Sankyo; Ono Pharmaceutical
 
Xiaohua Wu
No Relationships to Disclose
 
Lea Dutta
Employment - Eisai
Research Funding - Eisai
 
Cindy Xu
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Stephen Michael Keefe
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
John J. Lee
Employment - Merck Sharp & Dohme; Roche
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Roche
 
Sandro Pignata
Honoraria - AstraZeneca; MSD; pfizer; pharmamar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Pfizer; PharmaMar; Roche; tesaro
Research Funding - AstraZeneca (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)